<b>Conclusions</b>: WSXPs effectively improve FD symptoms, modulates gut microbiota, and exhibits potential benefits on hepatic lipid metabolism in vitro, possibly via the PI3K-Akt pathway. This evidence concerns the gene AKT1 and Fabry disease.